CXCR2 antagonists have been explored in non-cancer lung diseases (e.g., NCT01255592, NCT01006616) and in certain cancers such as castration-resistant prostate cancer (NCT03177187) and squamous cell carcinoma of the head and neck (NCT02499328). The gene discussed is CXCR2; the disease is cancer.